Trials / Unknown
UnknownNCT04162691
Single Cell Sequencing Analysis of Thymoma
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 10 (estimated)
- Sponsor
- Zhejiang Cancer Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to understand how genetics play a role in thymoma. Intratumoral heterogeneity is among the greatest challenges in precision cancer therapy. However, developments in high-throughput single-cell RNA sequencing (scRNA-seq) may now provide the statistical power to dissect the diverse cellular populations of tumors. This study aims to find out how it affects genetic and protein expression in patients with malignant thymoma, compared to Benign thymoma, at a single-cell level using a flow cytometry and RNA-sequencing protocol.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Tissue | Four 4-5 mm tissues of the thymoma |
Timeline
- Start date
- 2020-06-06
- Primary completion
- 2021-06-01
- Completion
- 2023-12-31
- First posted
- 2019-11-14
- Last updated
- 2023-01-13
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04162691. Inclusion in this directory is not an endorsement.